Evidence map›Paper›PMID 38451864›Full record

ArticleACS sensors2024

Improving the Performance of Selective Solid-State Nanopore Sensing Using a Polyhistidine-Tagged Monovalent Streptavidin.

Sara Abu Jalboush, Ian D Wadsworth, Komal Sethi, LeAnn C Rogers, Thomas Hollis, Adam R Hall

Open access · greenAbstract read
In one paragraph

Article in ACS sensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. DNA Nanoarray for Multiplexed RNA Detection With Single-Molecule Readout.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sara Abu JalboushDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States.ORCID 0009-0009-9913-4175
Ian D WadsworthVirginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, United States.
Komal SethiVirginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, United States.
LeAnn C RogersDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States.
Thomas HollisDepartment of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, United States.ORCID 0000-0002-4996-6346
Adam R HallVirginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, United States.ORCID 0000-0003-2053-6075
Virginia Tech - Wake Forest University School of Biomedical Engineering & Sciences · USWake Forest University · US

Funding

Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Kalyani Pyaram, Steven Allan Soper · 2019 to 2026
$21.5M
Single-Molecule Processing: Detection and Identification of Single DNAs, RNAs, and Proteins using Immobilized Nanoscale Enzymatic Reactors (INERs) and Nanoscale ElectrophoresisP41EB020594 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sunggook Park · 2015 to 2026
$15.2M
Detecting diverse nucleic acid biomarkers of cancer with solid-state nanoporesR33CA246448 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HALL, ADAM ROGER · 2020 to 2020
$1.1M
Molecular Detection of DNA Hydroxymethylation for Cancer ScreeningR21CA193067 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HALL, ADAM ROGER · 2015 to 2017
$649k
NCI NIH HHS R21 CA193067NCI NIH HHS R33 CA246448NIBIB NIH HHS P41 EB020594NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

Solid-state (SS-) nanopore sensing has gained tremendous attention in recent years, but it has been constrained by its intrinsic lack of selectivity. To address this, we previously established a novel SS-nanopore assay that produces translocation signals only when a target biotinylated nucleic acid fragment binds to monovalent streptavidin (MS), a protein variant with a single high-affinity biotin-binding domain. While this approach has enabled selective quantification of diverse nucleic acid biomarkers, sensitivity enhancements are needed to improve the detection of low-abundance translational targets. Because the translocation dynamics that determine assay efficacy are largely governed by constituent charge characteristics, we here incorporate a polyhistidine-tagged MS (hMS) to alter the component detectability. We investigate the effects of buffer pH, salt concentration, and SS-nanopore diameter on the performance with the alternate reagent, achieve significant improvements in measurement sensitivity and selectivity, and expand the range of device dimensions viable for the assay. We used this improvement to detect as little as 1 nM miRNA spiked into human plasma. Overall, our findings improve the potential for broader applications of SS-nanopores in the quantitative analyses of molecular biomarkers.

Indexed as

HistidineNanoporesNucleic AcidsBiomarkersHumansStreptavidinBiomarkersHistidineNucleic AcidspolyhistidineStreptavidinamplification-free detectionbiomarkersmonovalent streptavidinnucleic acidsselective detectionsolid-state nanopores

Identifiers

PMID38451864
PMCPMC11056946
OpenAlexW4392545572

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.